To include your compound in the COVID-19 Resource Center, submit it here.

Japan approves Tagrisso for first-line NSCLC

AstraZeneca plc (LSE:AZN; NYSE:AZN) said Japan's Ministry of Health, Labour and

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE